Carl Cummings - Icares Medicus Pres Subsidiary

6612 Stock  TWD 121.00  4.50  3.86%   

Insider

Carl Cummings is Pres Subsidiary of Icares Medicus
Phone886 3 657 9530
Webhttps://www.icaresmedicus.com

Icares Medicus Management Efficiency

The company has return on total asset (ROA) of 0.0835 % which means that it generated a profit of $0.0835 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1317 %, meaning that it generated $0.1317 on every $100 dollars invested by stockholders. Icares Medicus' management efficiency ratios could be used to measure how well Icares Medicus manages its routine affairs as well as how well it operates its assets and liabilities.
Icares Medicus has accumulated 2.8 M in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Icares Medicus has a current ratio of 5.2, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Icares Medicus until it has trouble settling it off, either with new capital or with free cash flow. So, Icares Medicus' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Icares Medicus sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Icares to invest in growth at high rates of return. When we think about Icares Medicus' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Yifeng TanFDC International Hotels
N/A
Huici ChenFDC International Hotels
N/A
ChungMao HsiaoCTBC Financial Holding
N/A
Guilan ZengFDC International Hotels
N/A
MuTsai ChenShanghai Commercial Savings
N/A
ChihHua YaoTaichung Commercial Bank
N/A
Yingxuan ZhuCTBC Financial Holding
N/A
TsungYi LiuTaichung Commercial Bank
N/A
YeongTaur ShannShanghai Commercial Savings
N/A
K ChenCTBC Financial Holding
N/A
Yushu TangFDC International Hotels
N/A
Aaron KingCTBC Financial Holding
87
ShanChung ChenShanghai Commercial Savings
N/A
MingHsiung HuangTaichung Commercial Bank
N/A
ChinMing LiaoTaichung Commercial Bank
N/A
ShengYung YangCTBC Financial Holding
N/A
Tsai HsiaCTBC Financial Holding
58
ChangHsing ChoCTBC Financial Holding
N/A
HsiuCheng HungShanghai Commercial Savings
N/A
Jinghong ZengFDC International Hotels
N/A
Yu ZhangFDC International Hotels
N/A
ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company was founded in 2011 and is based in Zhubei, Taiwan. ICARES MEDICUS is traded on Taiwan OTC Exchange in Taiwan. Icares Medicus (6612) is traded on Taiwan OTC Exchange in Taiwan and employs 14 people.

Management Performance

Icares Medicus Leadership Team

Elected by the shareholders, the Icares Medicus' board of directors comprises two types of representatives: Icares Medicus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Icares. The board's role is to monitor Icares Medicus' management team and ensure that shareholders' interests are well served. Icares Medicus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Icares Medicus' outside directors are responsible for providing unbiased perspectives on the board's policies.
TanLi Chen, Group Chief Financial Officer, Head of Finance & Accounting
Danli Chen, Group Chief Financial Officer, Head of Finance & Accounting
YingZong Yan, Director
Jerry Tseng, Vice Chairman of the Board, Group Chief Research & Development Officer
Kaiyuan Tan, Independent Director
JhihYing Guo, Independent Director
William Lee, General Manager, Director
Robert Cummings, General Manager-Subsidiary
Hongxun Ding, Independent Director
IhHoung Loh, Chairman of the Board, Group Chief Executive Officer
WenChu Tseng, Vice Chairman of the Board, Group Chief Research & Development Officer
ChunMing Lin, Deputy General Manager-Engineering
Zhiying Guo, Independent Director
Carl Cummings, Pres Subsidiary

Icares Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Icares Medicus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Icares Medicus

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Icares Medicus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icares Medicus will appreciate offsetting losses from the drop in the long position's value.

Moving together with Icares Stock

  0.836491 PegavisionPairCorr
  0.644107 BiotequePairCorr
  0.656499 Medeon BiodesignPairCorr

Moving against Icares Stock

  0.865312 Formosa Optical TechPairCorr
  0.862618 Eva Airways CorpPairCorr
  0.838284 Mitake InformationPairCorr
  0.814111 Chi Sheng ChemicalPairCorr
  0.782603 Evergreen Marine CorpPairCorr
The ability to find closely correlated positions to Icares Medicus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Icares Medicus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Icares Medicus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Icares Medicus to buy it.
The correlation of Icares Medicus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Icares Medicus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Icares Medicus moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Icares Medicus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Icares Stock Analysis

When running Icares Medicus' price analysis, check to measure Icares Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icares Medicus is operating at the current time. Most of Icares Medicus' value examination focuses on studying past and present price action to predict the probability of Icares Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icares Medicus' price. Additionally, you may evaluate how the addition of Icares Medicus to your portfolios can decrease your overall portfolio volatility.